Glycolysis-related five-gene signature correlates with prognosis and immune infiltration in gastric cancer

Table 1 Cox proportional risk model of the five genes from the differentially expressed gene analysis based on The Cancer Genome Atlas

Gene	HR	P value	Lower	Upper
SDC2	1.198408375	0.002623116	1.065124145	1.348371118
VCAN	1.254174878	0.005099287	1.070349846	1.469570562
ME1	1.207011799	0.019435313	1.030825077	1.413312031
PC	1.199767177	0.030505733	1.017278658	1.414992115
SOX9	0.811543291	0.04660378	0.660673598	0.996865191

HR: Hazard ratio; SDC2: Signature comprising syndecan 2; VCAN: Versican; ME1: Malic enzyme 1; PC: Pyruvate carboxylase; SOX9: SRY-box transcription factor 9.

Table 2 Parameters of five genes from least absolute shrinkage and selection operator regression analysis

Gene	coef	HR	Low CI	Up CI
SOX9	-0.188516073	0.811543291	0.660673598	0.996865191
PC	0.106222641	1.199767177	1.017278658	1.414992115
SDC2	0.14291442	1.198408375	1.065124145	1.348371118
VCAN	0.147527733	1.254174878	1.070349846	1.469570562
ME1	0.167403756	1.207011799	1.030825077	1.413312031

HR: Hazard ratio; CI: Confidence interval; SDC2: Signature comprising syndecan 2; VCAN: Versican; ME1: Malic enzyme 1; PC: Pyruvate carboxylase; SOX9: SRY-box transcription factor 9.